ENTRY       K06625                      KO
NAME        CDKN1A, P21, CIP1
DEFINITION  cyclin-dependent kinase inhibitor 1A
PATHWAY     ko04012  ErbB signaling pathway
            ko04066  HIF-1 signaling pathway
            ko04068  FoxO signaling pathway
            ko04110  Cell cycle
            ko04115  p53 signaling pathway
            ko04151  PI3K-Akt signaling pathway
            ko04921  Oxytocin signaling pathway
            ko05160  Hepatitis C
            ko05161  Hepatitis B
            ko05166  HTLV-I infection
            ko05169  Epstein-Barr virus infection
            ko05200  Pathways in cancer
            ko05202  Transcriptional misregulation in cancer
            ko05203  Viral carcinogenesis
            ko05205  Proteoglycans in cancer
            ko05206  MicroRNAs in cancer
            ko05214  Glioma
            ko05215  Prostate cancer
            ko05218  Melanoma
            ko05219  Bladder cancer
            ko05220  Chronic myeloid leukemia
DISEASE     H00030  Cervical cancer
BRITE       KEGG Orthology (KO) [BR:ko00001]
             Environmental Information Processing
              Signal transduction
               04012 ErbB signaling pathway
                K06625  CDKN1A, P21, CIP1; cyclin-dependent kinase inhibitor 1A
               04066 HIF-1 signaling pathway
                K06625  CDKN1A, P21, CIP1; cyclin-dependent kinase inhibitor 1A
               04068 FoxO signaling pathway
                K06625  CDKN1A, P21, CIP1; cyclin-dependent kinase inhibitor 1A
               04151 PI3K-Akt signaling pathway
                K06625  CDKN1A, P21, CIP1; cyclin-dependent kinase inhibitor 1A
             Cellular Processes
              Cell growth and death
               04110 Cell cycle
                K06625  CDKN1A, P21, CIP1; cyclin-dependent kinase inhibitor 1A
               04115 p53 signaling pathway
                K06625  CDKN1A, P21, CIP1; cyclin-dependent kinase inhibitor 1A
             Organismal Systems
              Endocrine system
               04921 Oxytocin signaling pathway
                K06625  CDKN1A, P21, CIP1; cyclin-dependent kinase inhibitor 1A
             Human Diseases
              Cancers
               05200 Pathways in cancer
                K06625  CDKN1A, P21, CIP1; cyclin-dependent kinase inhibitor 1A
               05202 Transcriptional misregulation in cancers
                K06625  CDKN1A, P21, CIP1; cyclin-dependent kinase inhibitor 1A
               05206 MicroRNAs in cancer
                K06625  CDKN1A, P21, CIP1; cyclin-dependent kinase inhibitor 1A
               05205 Proteoglycans in cancer
                K06625  CDKN1A, P21, CIP1; cyclin-dependent kinase inhibitor 1A
               05203 Viral carcinogenesis
                K06625  CDKN1A, P21, CIP1; cyclin-dependent kinase inhibitor 1A
               05214 Glioma
                K06625  CDKN1A, P21, CIP1; cyclin-dependent kinase inhibitor 1A
               05220 Chronic myeloid leukemia
                K06625  CDKN1A, P21, CIP1; cyclin-dependent kinase inhibitor 1A
               05218 Melanoma
                K06625  CDKN1A, P21, CIP1; cyclin-dependent kinase inhibitor 1A
               05219 Bladder cancer
                K06625  CDKN1A, P21, CIP1; cyclin-dependent kinase inhibitor 1A
               05215 Prostate cancer
                K06625  CDKN1A, P21, CIP1; cyclin-dependent kinase inhibitor 1A
              Infectious diseases
               05166 HTLV-I infection
                K06625  CDKN1A, P21, CIP1; cyclin-dependent kinase inhibitor 1A
               05161 Hepatitis B
                K06625  CDKN1A, P21, CIP1; cyclin-dependent kinase inhibitor 1A
               05160 Hepatitis C
                K06625  CDKN1A, P21, CIP1; cyclin-dependent kinase inhibitor 1A
               05169 Epstein-Barr virus infection
                K06625  CDKN1A, P21, CIP1; cyclin-dependent kinase inhibitor 1A
DBLINKS     GO: 0004861
GENES       HSA: 1026(CDKN1A)
            PTR: 747442(CDKN1A)
            PPS: 100977916(CDKN1A)
            GGO: 101126640(CDKN1A)
            PON: 100453682(CDKN1A)
            MCC: 719199(CDKN1A)
            MCF: 102136063(CDKN1A)
            MMU: 12575(Cdkn1a)
            RNO: 114851(Cdkn1a)
            CGE: 100689175(Cdkn1a)
            HGL: 101710552(Cdkn1a)
            TUP: 102490159(CDKN1A)
            CFA: 474890(CDKN1A)
            AML: 100484923
            FCA: 493943(CDKN1A)
            PTG: 102964051(CDKN1A)
            BTA: 513497(CDKN1A)
            BOM: 102268672(CDKN1A)
            PHD: 102326885(CDKN1A)
            CHX: 102179898(CDKN1A)
            SSC: 100152215(CDKN1A) 100623143
            CFR: 102509404(CDKN1A)
            BACU: 103005082(CDKN1A)
            LVE: 103080733(CDKN1A)
            ECB: 100064022(CDKN1A)
            MYB: 102245891(CDKN1A)
            MYD: 102773038(CDKN1A)
            PALE: 102894049(CDKN1A)
            MDO: 100029103(CDKN1A)
            SHR: 100926666(CDKN1A)
            GGA: 378914(CIP1)
            MGP: 100543182
            FAB: 101811025(CDKN1A)
            PHI: 102112135(CDKN1A)
            APLA: 101796138 101804945(CDKN1A)
            FPG: 101921917(CDKN1A)
            FCH: 102053837(CDKN1A)
            CLV: 102096820(CDKN1A)
            ASN: 102368723 102379358(CDKN1A)
            AMJ: 102567302 102568235(CDKN1A)
            PSS: 102450716(CDKN1A)
            CMY: 102939737(CDKN1A) 102940507
            ACS: 100555337
            PBI: 103052025(CDKN1A) 103053360
            XLA: 492305(cdkn1a)
            XTR: 100038054(cdkn1a)
            DRE: 100151416(cdkn1a)
            MZE: 101474553
            OLA: 101166216
            XMA: 102222169
            LCM: 102361382(CDKN1A)
            CMK: 103179079(cdkn1a) 103179335
REFERENCE   PMID:19440234
  AUTHORS   Abbas T, Dutta A
  TITLE     p21 in cancer: intricate networks and multiple activities.
  JOURNAL   Nat Rev Cancer 9:400-14 (2009)
///
